A Monovalent Chimpanzee Adenovirus Ebola Vaccine — Preliminary Report Scientists assessed a monovalent formulation of a chimpanzee adenovirus 3 (ChAd3)-vectored vaccine encoding the surface glycoprotein of Zaire ebolavirus, matched to the outbreak strain. After expedited regulatory and ethics approvals, 60 healthy adult volunteers received a single dose of the ChAd3 vaccine at one of three dose levels. Safety was assessed over the next four weeks. [New Engl J Med] Full Article | Press Release Class-Switched Memory B Cells Remodel BCRs within Secondary Germinal Centers The integrated specificity and function of individual memory B cell progeny revealed ongoing evolution of polyclonal antibody specificities through germinal center (GC)-specific transcriptional activity. Researchers demonstrate that vaccine boosts reactivate a cyclic program of GC function in class-switched memory B cells to remodel existing antibody specificities and enhance durable immunological protection. [Nat Immunol] Abstract | Press Release Dietary Restriction Protects against Experimental Cerebral Malaria via Leptin Modulation and T-Cell mTORC1 Suppression Investigators show that modulation of mouse immunometabolism through brief restriction of food intake (dietary restriction, DR) prevents neuropathology in experimental cerebral malaria. DR reduces mTORC1 activity in T cells, and this effect is abrogated upon leptin administration. [Nat Commun] Abstract | Press Release HIV-1 Tat Inhibits Phagocytosis by Preventing the Recruitment of Cdc42 to the Phagocytic Cup Researchers found that extracellular Tat, at the subnanomolar concentration present in the sera of HIV-1-infected patients, inhibits the phagocytosis of Mycobacterium avium or opsonized Toxoplasma gondii by human primary macrophages. This inhibition results from a defect in mannose- and Fcγ-receptor-mediated phagocytosis, respectively. [Nat Commun] Abstract IFN-γ and TNF Are Not Essential Parameters of CD4 T Cell Responses for Vaccine Control of Tuberculosis Investigators used a mouse model of T cell transfer and aerosolized Mycobacterium tuberculosis infection to assess the contributions of TNF, IFN-γ, and iNOS to vaccine efficacy. [J Infect Dis] Abstract HIV HIV-1-Triggered Release of Type I IFN by Plasmacytoid Dendritic Cells Induces BAFF Production in Monocytes Investigators report that HIV-1 upregulates B cell-activating factor (BAFF) expression and secretion by human monocytes. Moreover, they show that the virus-mediated production of BAFF by monocytes relies on a type I IFN response by a small percentage of plasmacytoid dendritic cells present in the monocyte cultures. [J Immunol] Abstract Retinoic Acid Imprints a Mucosal-Like Phenotype on Dendritic Cells with an Increased Ability to Fuel HIV-1 Infection To investigate how the gut microenvironment impacts the ability of dendritic cells (DCs) to drive HIV infection, scientists conditioned human immature monocyte-derived DCs with retinoic acid, before pulsing them with HIV and mixing them with autologous T cells. [J Immunol] Abstract Nef Promotes Evasion of HIV-1 Infected Cells from the CTLA-4-Mediated Inhibition of T Cell Activation As HIV-1 infects and replicates in activated CD4+ T cells, scientists investigated mechanisms by which HIV-1 modulates CTLA-4 expression to establish productive viral infection in these cells. They demonstrate that HIV-1 infection in activated CD4+ T cells was followed by Nef-mediated down-regulation of CTLA-4. [J Gen Virol] Abstract Don’t forget to subscribe to our sister publications: Human Immunology News and Immune Regulation News! |